Page last updated: 2024-11-07

gamma-glutamyl-3-carboxy-4-nitroanilide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

gamma-glutamyl-3-carboxy-4-nitroanilide: RN given refers to (S)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID104545
SCHEMBL ID1870730
MeSH IDM0061364

Synonyms (15)

Synonym
53602-84-9
(s)-5-((4-amino-4-carboxy-1-oxobutyl)amino)-2-nitrobenzoic acid
63699-78-5
SCHEMBL1870730
gamma-glutamyl-3-carboxy-4-nitroanilide
benzoic acid, 5-((4-amino-4-carboxy-1-oxobutyl)amino)-2-nitro-, (s)-
einecs 258-657-6
AKOS030213059
(s)-5-[(4-amino-4-carboxy-1-oxobutyl)amino]-2-nitrobenzoic acid
AS-71481
5-[(4s)-4-amino-4-carboxybutanamido]-2-nitrobenzoic acid
l-gamma-glutamyl-3-carboxy-4-nitroaniline
5-[[(4s)-4-amino-4-carboxybutanoyl]amino]-2-nitrobenzoic acid
5-[(4-amino-4-carboxy-1-hydroxybutylidene)amino]-2-nitrobenzoic acid
DTXSID20968375

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (80.00)18.7374
1990's1 (10.00)18.2507
2000's1 (10.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.23 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.17 (4.65)
Search Engine Demand Index22.84 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]